Ashton Thomas Private Wealth
RDY icon

Ashton Thomas Private Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

Ashton Thomas Private Wealth’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,729
Closed -$264K – 821
2024
Q4 		$264K Sell
16,729
-1,911
-10% -$28.7K 0.01% 666
2024
Q3 		$296K Buy
18,640
+810
+5% +$13K 0.02% 518
2024
Q2 		$272K Buy
17,830
+90
+0.5% +$1.29K 0.01% 510
2024
Q1 		$260K Sell
17,740
-19,545
-52% -$285K 0.01% 519
2023
Q4 		$519K Buy
37,285
+8,185
+28% +$109K 0.03% 416
2023
Q3 		$389K Buy
+29,100
New +$394K 0.03% 437

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ashton Thomas Private Wealth's RDY Position: Q1 2025 in Review

Ashton Thomas Private Wealth sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 16,729 shares — an estimated $264K sold.

Ashton Thomas Private Wealth first reported a position in RDY in Q3 2023 and held it in 6 quarters. The position peaked at $519K in Q4 2023. 246 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Ashton Thomas Private Wealth reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 16,729 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $264K.
  • Ashton Thomas Private Wealth first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 6 quarters.
  • Ashton Thomas Private Wealth's Dr. Reddy's Laboratories position peaked at $519K in Q4 2023.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2025, filed 16 May 2025.